Apr 01, 2021 / Presentations Mandated report: Assessing the impact of recent changes to Medicare’s clinical laboratory fee schedule payments Research Areas: Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans
Mar 30, 2021 / Presentations Improving Medicare’s policies for separately payable drugs in the hospital outpatient prospective payment system Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals
Mar 15, 2021 / Reports March 2021 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 15, 2021 / Chapters Chapter 3: Hospital inpatient and outpatient services (March 2021 Report) Research Areas: Hospitals, Medicare Spending and Financing
Mar 15, 2021 / Press Releases MedPAC releases March 2021 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 10, 2021 Mar21 Medpac Report To The Congress Secv2 Research Areas: Physicians And Other Health Professionals
Mar 09, 2021 / Transcripts March 2021 meeting transcript Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 05, 2021 / Presentations Separately payable drugs in the hospital outpatient prospective payment system Research Areas: Ambulatory Care Settings, Drugs, Devices, and Tests, Hospitals
Mar 05, 2021 / Presentations Revising Medicare’s indirect medical education payments to better reflect teaching hospitals’ costs Research Areas: Hospitals, Physicians And Other Health Professionals, Regional Issues
Jan 25, 2021 / Comment Letters MedPAC comment on CMS’s interim final rule on the Most Favored Nation Model Research Areas: Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Private Plans, Quality